Department of Emergency Medicine

Investigational glaucoma drug studied to prevent respiratory distress in COVID-19 patients

Vanderbilt University Medical Center is evaluating razuprotafib, a drug being investigated for the treatment of glaucoma, in a new randomized, investigational trial for the prevention and treatment of acute respiratory distress syndrome (ARDS) in adult patients with moderate to severe COVID-19.

About half of health care workers positive for COVID-19 by serology have no symptoms

The IVY Research Network has completed initial studies evaluating the epidemiology of COVID-19 in health care workers and patients.

Major U.S. trial closes showing no benefit for hydroxychloroquine in COVID-19

The Outcomes Related to COVID-19 Treated with Hydroxychloroquine among In-patients with Symptomatic Disease (ORCHID) trial stopped enrolling new patients based on the fourth scheduled interim analysis showing no evidence of benefit or harm. 

Erik Hess named new Chair of Department of Emergency Medicine

Erik Hess, MD, MSc, professor and interim chair of the Department of Emergency Medicine at the University of Alabama at Birmingham (UAB) School of Medicine, has been named the new chair of the Department of Emergency Medicine for Vanderbilt University Medical Center. He will join the faculty on July 1.

Study launched to test hydroxychloroquine as treatment for COVID-19

Study aims to shield health workers from COVID-19 infection

VUMC is playing a key role in a national effort to establish a registry of U.S. health care workers and test whether the anti-malarial drug hydroxychloroquine (HCQ) will protect them, their patients and their families from COVID-19.

1 5 6 7 8 9 12